Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage revision applications from currently funded NCI R01 research projects to incorporate new technical approaches or devices developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. The goal is to accelerate cancer research by promoting independent validation and adoption of emerging technologies. Key aspects of this opportunity include: * Revision applications to expand upon original research questions or accelerate progress for parent studies * Incorporation of new technical approaches or devices developed through NCI IMAT program support * Interdisciplinary collaboration in developing innovative tools and methods for cancer research * Awards meant to incentivize validation and accelerate adoption of emerging technologies * Eligibility includes various types of organizations such as nonprofits, institutions of higher education, and small businesses.